Elspeth M. Beauchamp

1.9k total citations
32 papers, 1.5k citations indexed

About

Elspeth M. Beauchamp is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Elspeth M. Beauchamp has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Hematology and 10 papers in Oncology. Recurrent topics in Elspeth M. Beauchamp's work include Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Elspeth M. Beauchamp is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Elspeth M. Beauchamp collaborates with scholars based in United States, Canada and France. Elspeth M. Beauchamp's co-authors include Aykut Üren, Leonidas C. Platanias, Jeffrey A. Toretsky, Gülay Bulut, Jeffrey S. Rubin, Yoshimi Endo, Jessica K. Altman, Shannon Fallen, Lymor Ringer and Metin Özdemirli and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Elspeth M. Beauchamp

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elspeth M. Beauchamp United States 18 1.1k 288 191 150 141 32 1.5k
Gabriel Bretones Spain 16 761 0.7× 323 1.1× 80 0.4× 181 1.2× 105 0.7× 24 1.1k
Roberto Bellelli United Kingdom 16 1.1k 0.9× 283 1.0× 135 0.7× 245 1.6× 75 0.5× 23 1.3k
Marina R. Carpinelli Australia 15 855 0.8× 249 0.9× 104 0.5× 144 1.0× 265 1.9× 30 1.5k
Alan W. Lau United States 19 1.5k 1.4× 638 2.2× 294 1.5× 211 1.4× 57 0.4× 20 2.1k
Alan G. Rosmarin United States 23 985 0.9× 332 1.2× 122 0.6× 195 1.3× 86 0.6× 47 1.7k
Ignacio García‐Tuñón Spain 22 788 0.7× 386 1.3× 166 0.9× 224 1.5× 92 0.7× 45 1.5k
Debora Rasio Italy 16 876 0.8× 467 1.6× 146 0.8× 352 2.3× 226 1.6× 25 1.4k
Jenny Yuan United States 11 1.1k 1.0× 462 1.6× 106 0.6× 361 2.4× 102 0.7× 14 1.7k
Carmela Calés Spain 18 1.3k 1.2× 370 1.3× 225 1.2× 196 1.3× 251 1.8× 34 2.0k
Nianxiang Zhang United States 25 1.6k 1.4× 315 1.1× 84 0.4× 328 2.2× 121 0.9× 47 2.1k

Countries citing papers authored by Elspeth M. Beauchamp

Since Specialization
Citations

This map shows the geographic impact of Elspeth M. Beauchamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elspeth M. Beauchamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elspeth M. Beauchamp more than expected).

Fields of papers citing papers by Elspeth M. Beauchamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elspeth M. Beauchamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elspeth M. Beauchamp. The network helps show where Elspeth M. Beauchamp may publish in the future.

Co-authorship network of co-authors of Elspeth M. Beauchamp

This figure shows the co-authorship network connecting the top 25 collaborators of Elspeth M. Beauchamp. A scholar is included among the top collaborators of Elspeth M. Beauchamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elspeth M. Beauchamp. Elspeth M. Beauchamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izquierdo, Javier, Candice Mazewski, Elspeth M. Beauchamp, et al.. (2025). Discovery of Potent and Selective MNK Kinase Inhibitors for the Treatment of Leukemia. Journal of Medicinal Chemistry. 68(5). 5824–5844. 1 indexed citations
2.
Perez, Ricardo E., Elspeth M. Beauchamp, Mariafausta Fischietti, et al.. (2024). Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AML. PubMed. 1(4). 100037–100037.
3.
Saleiro, Diana, Ewa M. Kościuczuk, Mariafausta Fischietti, et al.. (2023). Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells. Cancer Research Communications. 3(5). 943–951. 3 indexed citations
4.
Fischietti, Mariafausta, Frank Eckerdt, Ricardo E. Perez, et al.. (2022). SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression. Cancer Research Communications. 2(9). 966–978. 8 indexed citations
5.
Saleiro, Diana, Ewa M. Kościuczuk, Frank Eckerdt, et al.. (2022). Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms. Nature Communications. 13(1). 1750–1750. 15 indexed citations
6.
Fischietti, Mariafausta, Frank Eckerdt, Ahmet Arslan, et al.. (2021). Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. Oncogene. 40(18). 3273–3286. 9 indexed citations
7.
Eisfelder, Bartholomew J., Caner Saygin, Joseph Wynne, et al.. (2021). OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia. Blood Cancer Journal. 11(3). 48–48. 9 indexed citations
8.
Eckerdt, Frank, Jonathan B. Bell, Elspeth M. Beauchamp, et al.. (2019). Potent Antineoplastic Effects of Combined PI3Kα–MNK Inhibition in Medulloblastoma. Molecular Cancer Research. 17(6). 1305–1315. 13 indexed citations
9.
Eckerdt, Frank, Jessica Clymer, Jonathan B. Bell, et al.. (2019). Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma. Scientific Reports. 9(1). 12822–12822. 28 indexed citations
10.
Mishra, Rama K., Matthew R. Clutter, Ewa M. Kościuczuk, et al.. (2019). Discovery of novel Mnk inhibitors using mutation‐based induced‐fit virtual high‐throughput screening. Chemical Biology & Drug Design. 94(4). 1813–1823. 9 indexed citations
11.
Beauchamp, Elspeth M., Sameem Abedin, Mariafausta Fischietti, et al.. (2018). Identification and targeting of novel CDK9 complexes in acute myeloid leukemia. Blood. 133(11). 1171–1185. 30 indexed citations
12.
Beauchamp, Elspeth M., Ewa M. Kościuczuk, Dhaval Nanavati, et al.. (2014). Direct Binding of Arsenic Trioxide to AMPK and Generation of Inhibitory Effects on Acute Myeloid Leukemia Precursors. Molecular Cancer Therapeutics. 14(1). 202–212. 24 indexed citations
13.
Goussetis, Dennis J., Elspeth M. Beauchamp, Ewa M. Kościuczuk, et al.. (2014). Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors. Cancer Biology & Therapy. 15(4). 473–478. 13 indexed citations
14.
Beauchamp, Elspeth M. & Leonidas C. Platanias. (2012). The evolution of the TOR pathway and its role in cancer. Oncogene. 32(34). 3923–3932. 130 indexed citations
15.
Beauchamp, Elspeth M. & Aykut Üren. (2012). A New Era for an Ancient Drug. Vitamins and hormones. 88. 333–354. 27 indexed citations
16.
Beauchamp, Elspeth M., Eric Glasgow, Sivanesan Dakshanamurthy, et al.. (2011). Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 31(3). 269–281. 139 indexed citations
17.
Bulut, Gülay, Shannon Fallen, Elspeth M. Beauchamp, et al.. (2011). Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice. PLoS ONE. 6(11). e27243–e27243. 47 indexed citations
18.
Beauchamp, Elspeth M., Lymor Ringer, Gülay Bulut, et al.. (2010). Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. Journal of Clinical Investigation. 121(1). 148–160. 274 indexed citations
19.
Beauchamp, Elspeth M., Olga Rodríguez, Christopher Albanese, Jeffrey A. Toretsky, & Aykut Üren. (2010). Abstract 3409: Arsenic trioxide inhibits Ewing sarcoma growth by blocking Hedgehog/GLI pathway. Cancer Research. 70(8_Supplement). 3409–3409. 1 indexed citations
20.
Beauchamp, Elspeth M., Gülay Bulut, Ogan D. Abaan, et al.. (2009). GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein. Journal of Biological Chemistry. 284(14). 9074–9082. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Bretones Breakdown of academic impact, for papers by Roberto Bellelli Breakdown of academic impact, for papers by Marina R. Carpinelli Breakdown of academic impact, for papers by Alan W. Lau Breakdown of academic impact, for papers by Alan G. Rosmarin Breakdown of academic impact, for papers by Ignacio García‐Tuñón Breakdown of academic impact, for papers by Debora Rasio Breakdown of academic impact, for papers by Jenny Yuan Breakdown of academic impact, for papers by Carmela Calés Breakdown of academic impact, for papers by Nianxiang Zhang
Rankless by CCL
2026